Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs PubMatic Inc (PUBM) Price & Performance

Axogen IncTrade
PubMatic IncTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs PubMatic Inc — how do they compare? Axogen Inc trades at $49.23 (market cap $2.61B), while PubMatic Inc trades at $17.25 (market cap $804.41M). The key difference: Axogen Inc is far larger — about 3.2× PubMatic Inc's market cap. Which is the better fit depends on your goals.

AXGNPUBM
Market Cap
$2.61B$804.41M
Sector
TechnologyTechnology
52-Week High
$48.48$17.78
52-Week Low
$14.16$6.28
Enterprise Value
$2.52B$707.54M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN trades at $49.10, up 1.82% with strong technical momentum and bullish analyst sentiment. The stock shows robust revenue growth (23.1% in Q2 2026) and raised full-year guidance to $279 million, though profitability remains negative with a -13.36% net margin. Technical indicators show overbought RSI levels but strong moving average support, while institutional ownership and analyst consensus (84% buy ratings) signal confidence in the company's nerve care platform expansion.

The outlook remains positive given strong revenue momentum and regulatory advantages, but investors face execution risks from persistent losses and high valuation multiples. Upside potential exists toward the $54.33 consensus target if margin improvements materialize, though volatility may persist near current resistance levels.

PubMatic Inc

PubMatic trades at $17.39, down 2.08% today, with a bullish technical outlook from moving averages but overbought RSI signals. Revenue reached $282.93M in 2025, though net income was negative. Recent Q2 2026 earnings beat expectations with 10.5% revenue growth, and the company appointed a new Chief Revenue Officer to drive AI-advertising growth.

The stock offers upside to the $20.83 consensus price target, supported by analyst buy ratings and operational cash flow strength. Risks include persistent unprofitability, high P/E ratio, and CFO transition. Positive sentiment from recent earnings beats and strategic hires suggests potential for recovery if margin improvements continue.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About PubMatic Inc

PubMatic Inc is engaged in the digital advertising business. The company provides a specialized cloud infrastructure platform that enables real-time programmatic advertising transactions. The platform helps independent app developers and publishers to control and maximize their digital advertising businesses.

Read more on PUBM